Janssen Pharma Seeks Green Light for Controlled Imports
Published Date: 2/13/2025
Notice
Summary
Janssen Pharmaceuticals wants to get official approval to bring in certain controlled substances into the U.S. This affects Janssen and anyone tracking drug imports, with no immediate cost changes but a key step in their business process. The approval timing will be important for their future shipments and compliance.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in